Correction to “Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy”  

作　　者：Chenyu Wang Linglin Feng Xiangkun Yang FeiWang Weiyue Lu 

机构地区：[1]Department of Pharmaceutics,School of Pharmacy,Fudan University,Key Laboratory of Smart Drug Delivery(Fudan University),Ministry of Education&PLA,Shanghai 201203,China [2]State Key Laboratory of Molecular Engineering of Polymers(Fudan University),Shanghai 200433,China [3]Shanghai Institute of Planned Parenthood Research,Key Laboratory of Contraceptives and Devices Research,NPFC of China,Shanghai 200032,China

出　　处：《Asian Journal of Pharmaceutical Sciences》2022年第4期610-611,共2页亚洲药物制剂科学（英文）

摘　　要：In the original version of this article on p 122, two inappropriate images were placed in B and C of Fig. 1, which didn’t represent the group of FA-PEG-LS and PEG-LS/VCR. In the revised graphic provided below, the appropriate images are used.These corrections do not change the results and conclusions of this work.

关 键 词：CORRECTION revised CANCER 

分 类 号：R730.5[医药卫生—肿瘤]